High-Frequency Basal Cell Carcinoma: Risk Factors, Histological and Anatomical Patterns
Methods:The first case (fig. 1) involves a 56-year-old male diagnosed with metatypical retro auricular basal cell carcinoma (BCC) with secondary lymph node involvement, resected in 2019.In 2021, he developed a local and pulmonary recurrence.In April 2022, treatment with vismodegib (150 mg/day) was initiated, resulting in an excellent response and good tolerance.
Authors
- Mariano Suppa (ORCID: https://orcid.org/0000-0002-9266-0342)
- Klaus Wunderlich (ORCID: https://orcid.org/0009-0009-2404-1433)
- V. del Mármol (ORCID: https://orcid.org/0000-0002-4359-0667)
- H. Njimi
Institutions
- Erasmus Hospital (BE)
Publication Details
- Journal
- EJC Skin Cancer
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ejcskn.2025.100323
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00